UPDATE: UBS Upgrades Biogen (BIIB) to Buy, 'Aduhelm is going to get used'
Tweet Send to a Friend
(Updated - June 10, 2021 3:58 PM EDT)
UBS analyst Colin Bristow upgraded Biogen (NASDAQ: BIIB) from Neutral to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Colin Bristow upgraded Biogen (NASDAQ: BIIB) from Neutral to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
